Pathogenic Protein Seeding in Alzheimer Disease and Other Neurodegenerative Disorders

被引:470
作者
Jucker, Mathias [1 ,2 ]
Walker, Lary C. [3 ,4 ]
机构
[1] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany
[2] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany
[3] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA
[4] Emory Univ, Dept Neurol, Atlanta, GA 30329 USA
关键词
CEREBRAL BETA-AMYLOIDOSIS; A-BETA; ALPHA-SYNUCLEIN; INTRACEREBRAL INFUSION; EXOGENOUS INDUCTION; NERVOUS-SYSTEM; PRION STRAINS; LEWY BODIES; LONG-TERM; TAU;
D O I
10.1002/ana.22615
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The misfolding and aggregation of specific proteins is a seminal occurrence in a remarkable variety of neurodegenerative disorders. In Alzheimer disease (the most prevalent cerebral proteopathy), the two principal aggregating proteins are beta-amyloid (A beta) and tau. The abnormal assemblies formed by conformational variants of these proteins range in size from small oligomers to the characteristic lesions that are visible by optical microscopy, such as senile plaques and neurofibrillary tangles. Pathologic similarities with prion disease suggest that the formation and spread of these proteinaceous lesions might involve a common molecular mechanism-corruptive protein templating. Experimentally, cerebral beta-amyloidosis can be exogenously induced by exposure to dilute brain extracts containing aggregated A beta seeds. The amyloid-inducing agent probably is A beta itself, in a conformation generated most effectively in the living brain. Once initiated, A beta lesions proliferate within and among brain regions. The induction process is governed by the structural and biochemical nature of the A beta seed, as well as the attributes of the host, reminiscent of pathogenically variant prion strains. The concept of prionlike induction and spreading of pathogenic proteins recently has been expanded to include aggregates of tau, alpha-synuclein, huntingtin, superoxide dismutase-1, and TDP-43, which characterize such human neurodegenerative disorders as frontotemporal lobar degeneration, Parkinson/Lewy body disease, Huntington disease, and amyotrophic lateral sclerosis. Our recent finding that the most effective A beta seeds are small and soluble intensifies the search in bodily fluids for misfolded protein seeds that are upstream in the proteopathic cascade, and thus could serve as predictive diagnostics and the targets of early, mechanism-based interventions. Establishing the clinical implications of corruptive protein templating will require further mechanistic and epidemiologic investigations. However, the theory that many chronic neurodegenerative diseases can originate and progress via the seeded corruption of misfolded proteins has the potential to unify experimental and translational approaches to these increasingly prevalent disorders. ANN NEUROL 2011;70:532-540
引用
收藏
页码:532 / 540
页数:9
相关论文
共 110 条
[41]   Aβ and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease [J].
Guo, JP ;
Arai, T ;
Miklossy, J ;
McGeer, PL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (06) :1953-1958
[42]   Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide [J].
Haass, Christian ;
Selkoe, Dennis J. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (02) :101-112
[43]   α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells [J].
Hansen, Christian ;
Angot, Elodie ;
Bergstrom, Ann-Louise ;
Steiner, Jennifer A. ;
Pieri, Laura ;
Paul, Gesine ;
Outeiro, Tiago F. ;
Melki, Ronald ;
Kallunki, Pekka ;
Fog, Karina ;
Li, Jiia-Yi ;
Brundin, Patrik .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (02) :715-725
[44]   AN ANATOMICAL CASCADE HYPOTHESIS FOR ALZHEIMERS-DISEASE [J].
HARDY, J .
TRENDS IN NEUROSCIENCES, 1992, 15 (06) :200-201
[45]   Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].
Hardy, J ;
Selkoe, DJ .
SCIENCE, 2002, 297 (5580) :353-356
[46]   GSK3: A possible link between beta amyloid peptide and tau protein [J].
Hernandez, Felix ;
Gomez de Barreda, Elena ;
Fuster-Matanzo, Almudena ;
Lucas, Jose J. ;
Avila, Jesus .
EXPERIMENTAL NEUROLOGY, 2010, 223 (02) :322-325
[47]   Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide [J].
Hu, Xiaoyan ;
Crick, Scott L. ;
Bu, Guojun ;
Frieden, Carl ;
Pappu, Rohit V. ;
Lee, Jin-Moo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (48) :20324-20329
[48]   Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease [J].
Ittner, Lars M. ;
Goetz, Juergen .
NATURE REVIEWS NEUROSCIENCE, 2011, 12 (02) :67-72
[49]   Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration [J].
Jin, Ming ;
Shepardson, Nina ;
Yang, Ting ;
Chen, Gang ;
Walsh, Dominic ;
Selkoe, Dennis J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (14) :5819-5824
[50]   The neuronal origin hypothesis of cerebral amyloid angiopathy [J].
Jucker, Mathias .
Alzheimer: 100 Years and Beyond, 2006, :221-223